Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020

•TORS & ND offer higher 5-year OS & RFS rates in OPSCC treatment.•HPV-positive/p16-positive patients show better OS with TORS.•Minimal adjuvant therapy achieves competitive survival rates.

Saved in:
Bibliographic Details
Published inOral oncology Vol. 152; p. 106811
Main Author Dharmalingam Jothinathan, Mukesh Kumar
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.05.2024
Subjects
Adult
Aged
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
Female
Humans
Male
Middle Aged
Neoplasm Staging
Oropharyngeal Neoplasms - pathology
Oropharyngeal Neoplasms - surgery
Robotic Surgical Procedures - methods
Squamous Cell Carcinoma of Head and Neck - pathology
Squamous Cell Carcinoma of Head and Neck - surgery
Treatment Outcome
Online AccessGet full text

Cover

More Information
Summary:•TORS & ND offer higher 5-year OS & RFS rates in OPSCC treatment.•HPV-positive/p16-positive patients show better OS with TORS.•Minimal adjuvant therapy achieves competitive survival rates.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1368-8375
1879-0593
DOI:10.1016/j.oraloncology.2024.106811